Tetanus-Diphtheria Toxoid (Td)

BIOLOGICAL2 trials

Sponsors

Katy Peters, MD, PhD, Mustafa Khasraw, MBChB, MD, FRCP, FRACP

Conditions

Brain CancerBrain Neoplasm, PrimaryBrain Neoplasms, RecurrentBrain TumorCancer of the BrainGlioblastoma

Phase 1

IDH1 Peptide Vaccine for Recurrent Grade II Glioma

CompletedNCT02193347

Katy Peters, MD, PhDBrain Cancer, Brain Neoplasm, Primary, Brain Neoplasms, Recurrent +2

Start: 2016-01-28End: 2020-02-03Updated: 2023-12-01

Phase 2

Immunotherapy Targeted Against Cytomegalovirus in Patients With Newly-Diagnosed WHO Grade IV Unmethylated Glioma

TerminatedNCT03927222

Mustafa Khasraw, MBChB, MD, FRCP, FRACPGlioblastoma

Start: 2019-09-30End: 2023-02-10Updated: 2024-04-08

Related Papers

IMMU-06. TARGETING IDH1 MUTANT GRADE II RECURRENT GLIOMAS USING A PEPTIDE VACCINATION STRATEGY

Neuro-Oncology Advances2021-09-213 citations

Emerging targets for anticancer vaccination: IDH.

2021-07-1316 citations